Observation
Observation is an intervention with 396 clinical trials. Currently 89 active trials ongoing. Historical success rate of 88.6%.
Success Metrics
Based on 178 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
26
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.8%
178 of 205 finished
13.2%
27 ended early
89
trials recruiting
396
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Clinical Trials (396)
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
The Association Between Fever and CDKL5 Deficiency Disorder: a Nationwide Survey
Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Identifying and Treating Depression in the Orthopaedic Trauma Population
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)
Pediatric Normative Markerless Movement Analysis
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)
Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
GU-01: Glycyrrhizin in Prostate Cancer
PPV vs PVI in the Supine and Prone Position
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
MPN Childhood Registry
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 396